The Road to Remission: Optimizing Pharmacological Treatment of Unipolar Depression (PDF)
List Price: $0.00
Member Price: $0.00


Patients with major depressive disorder are much more likely to achieve response than remission, yet true wellness is the ultimate goal. If one understands both the neurobiology behind the spectrum of symptoms that are associated with depressive disorders, and the mechanisms behind the spectrum of drugs characterized as antidepressants, then it is possible to apply informed strategies to the selection of first-line treatment as well as the management of residual symptoms and side effects, which ideally will lead to hastened remission and return to wellness.

Target Audience
This activity has been developed for nurse practitioners specializing in psychiatry. There are no prerequisites. All other health care providers interested in psychopharmacology are welcome for advanced study.

Learning Objectives
After completing the activity, you should be better able to:
 - Identify risk factors for nonadherence to antidepressant treatment
 - Employ strategies to assess treatment effectiveness and adherence over time
 - Implement evidence-based treatment adjustments for patients with inadequate antidepressant response

Accreditation and Credit Designation Statements

The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Neuroscience Education Institute designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Society for the Advancement of Pharmacotherapy (ASAP), Division 55 of the American Psychological Association, is approved by the American Psychological Association to sponsor continuing education for psychologists. ASAP maintains responsibility for this program and its content. 

The American Society for the Advancement of Pharmacotherapy designates this program for 2.5 CE credits for psychologists. 

Nurses: for all of your CNE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content of this activity pertains to pharmacology and is worth 2.5 continuing education hours of pharmacotherapeutics.

Physician Assistants:
the NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the AMA (providers accredited by the ACCME). A certificate of participation for completing this activity is available.

Note: the content of this electronic book activity also exists as a print monograph under the same title. If you received CME credit for the print monograph version, you will not be able to receive credit again for completing this electronic book version.

This activity is provided by the Neuroscience Education Institute.
Additionally provided by the American Society for the Advancement of Pharmacotherapy.

This activity is supported by an unrestricted educational grant from Takeda Pharmaceuticals International, Inc.

Date of Release/Expiration
Print Monograph Released: August, 2015
Electronic Books Released: December, 2015
CME Credit Expires: August, 2018